Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of SB-649868 in elderly and female participants for insomnia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• SB-649868

Snippet

Sponsor: GlaxoSmithKline | Conditions: Insomnia | Phase 1 | Status: WITHDRAWN